Mucormicosis pulmonar y diabetes mellitus: Buena respuesta al tratamiento médico. Reporte de un caso y revisión de la bibliografía

Pulmonary mucormycosis is a relatively uncommon but an important opportunistic fungal infection in immunocompromised patients. It may be acquired by inhalation of spores into the lungs. The pathogenic hallmark of mucormycosis is vascular invasion resulting in thrombosis and tissue infarction/necrosi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Strazza , Luciana Renata, Guzmán, José, Ghelli , Raúl Eduardo, Carrizo, Silvia, Zaya, Alejandro, Cazaux, Alexis, Cambursano , Víctor Hugo
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2019
Materias:
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/25578
Aporte de:
Descripción
Sumario:Pulmonary mucormycosis is a relatively uncommon but an important opportunistic fungal infection in immunocompromised patients. It may be acquired by inhalation of spores into the lungs. The pathogenic hallmark of mucormycosis is vascular invasion resulting in thrombosis and tissue infarction/necrosis. The diagnosis can be difficult since presentation does not differ from other forms of pneumonia. Risk factors include neutropenia, haematologic malignancies, uncontrolled diabetes mellitus, skin hurns and deferoxamine therapy in dialysis patients. Early recognitiori, control of underlying diseases and medical-surgical aggressive management are warranted to better outcomes. Pulmonary mucormycosis has a high mortality and medical treatment strategy alorie has been associated in several studies to greater mortality. We describe a case of pulmonary mucormicosis with favorable evolution only under medical treatment. We reviewed the bibliography.